A total of 709,689€ has been received, and projects will soon begin internationally
IDIBELL receives funding for four research projects with an international consortium Read More »
During the progression of atherosclerosis, significant changes occur in the length of certain mRNAs
New study looks at how mRNAs change during atherosclerosis progression Read More »
It is confirmed that digital tools are able to provide effective emotional support
Digital tools also generate a strong bond between patients and professionals Read More »
AES’ grants stimulate biomedical research at IDIBELL once again
The ISCIII grants financial aid to 17 IDIBELL health research projects Read More »
The importance of a correct interpretation of gene variants is highlighted, since not all of them are hereditary or related to a predisposition to cancer.
New study sets new recommendations for studying TP53 gene linked to hereditary cancer Read More »
The Barradas Auditorium was filled to the last seat to celebrate the International Day of Women and Girls in Science
The therapeutic efficacy of a new compound against psoriasis is confirmed
A light-activated drug to fight psoriasis Read More »
The event will take place on Thursday, February 6, at the Barradas Auditorium in L’Hospitalet and will commemorate the International Day of Women and Girls in Science.
A multifaceted look at the role of women in biomedical research will be the focus of this year’s sLHam, which will talk about women as researchers and as researched.
In its 8th edition, the sLHam will have two sessions, a morning session for students and an afternoon session for the general public.
Aptadel Therapeutics receives half a million dollars for a preclinical research program against Ewing’s sarcoma.
New investment in the research against Ewing’s sarcoma Read More »
A multicenter collaboration leaded by the Bellvitge Biomedical Research Institute (IDIBELL), the Catalan Institute of Oncology (ICO) and the Germans Trias i Pujol Research Institute (IGTP) identified a potential new treatment for an aggressive sarcoma arising in the nerves. The findings have been published in the journal Clinical Cancer Research.
